# Cuba Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Cuba HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Cuba (CUB)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $10.8M
- Products: 27
- Buyer markets: 35
- Average CAGR: +17.3%
- Global sector size: $466.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $239.2B | $7.0M | $90.0B | +4.6% | 31 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $85.7B | $1.7M | $32.8B | +36.4% | 14 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $24.8B | $532.2K | $21.5B | -7.0% | 12 | +0.3% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $23.8B | $804.9K | $12.4B | +17.9% | 7 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $22.1B | $78.6K | $9.8B | +9.3% | 9 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.0B | $21.3K | $8.7B | +29.9% | 8 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $4.9B | $2.2K | $5.2B | +1.4% | 4 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $7.8B | $512.9 | $4.8B | +32.0% | 4 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $5.8B | $909.3 | $4.6B | -34.9% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $38.4K | $3.9B | +32.4% | 5 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $5.0B | $16.3K | $3.5B | +1.6% | 6 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.9B | $78.6K | $1.9B | +39.9% | 3 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $2.9B | $258.3K | $1.7B | +44.4% | 2 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $1.9B | $15.1K | $1.4B | -26.6% | 2 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $1.5B | $19.6K | $1.3B | -29.6% | 2 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.8B | $190.3K | $1.2B | +396.1% | 2 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.2B | $47.9K | $1.1B | -20.8% | 1 | +0.0% |
| HS 300213 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | $1.2B | $283.8 | $1.0B | -23.8% | 2 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $116.6 | $871.2M | +79.3% | 1 | +0.0% |
| HS 380891 - Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $1.6B | $13.5 | $713.1M | -38.9% | 1 | +0.0% |
| HS 300432 - Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | $1.1B | $2.5K | $694.8M | +11.9% | 1 | +0.0% |
| HS 284390 - Inorganic or organic compounds: of precious metals (excluding gold and silver), whether or not chemically defined, amalgams of precious metals | $453.9M | $8.2 | $560.2M | -12.8% | 1 | +0.0% |
| HS 310520 - Fertilizers, mineral or chemical: containing the three fertilizing elements nitrogen, phosphorus and potassium | $473.9M | $90.6 | $508.2M | -37.0% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $841.9M | $102.1 | $482.2M | -30.9% | 1 | +0.0% |
| HS 293371 - Heterocyclic compounds: lactams: 6-hexanelactam (epsilon-caprolactam) | $483.5M | $2.6K | $457.3M | -19.5% | 1 | +0.0% |
| HS 350691 - Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | $462.6M | $1.2K | $397.4M | +96.3% | 1 | +0.0% |
| HS 300431 - Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale | $369.0M | $32.3 | $392.9M | -15.9% | 1 | +0.0% |

## Best markets

- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Germany (DEU): $28.9B calculated opportunity across 15 products.
- China (CHN): $20.1B calculated opportunity across 9 products.
- Belgium (BEL): $15.0B calculated opportunity across 2 products.
- Netherlands (NLD): $13.2B calculated opportunity across 5 products.
- Spain (ESP): $12.2B calculated opportunity across 9 products.
- Italy (ITA): $11.9B calculated opportunity across 10 products.
- France (FRA): $10.5B calculated opportunity across 9 products.
- Japan (JPN): $10.0B calculated opportunity across 5 products.
- Mexico (MEX): $10.0B calculated opportunity across 8 products.
- Canada (CAN): $7.9B calculated opportunity across 5 products.
- United Kingdom (GBR): $7.7B calculated opportunity across 5 products.

## Growth stars

- HS 330290: +396.1% average CAGR, $1.2B calculated opportunity.
- HS 350691: +96.3% average CAGR, $397.4M calculated opportunity.
- HS 293339: +79.3% average CAGR, $871.2M calculated opportunity.
- HS 300439: +44.4% average CAGR, $1.7B calculated opportunity.
- HS 300390: +39.9% average CAGR, $1.9B calculated opportunity.
- HS 300215: +36.4% average CAGR, $32.8B calculated opportunity.
- HS 330300: +32.4% average CAGR, $3.9B calculated opportunity.
- HS 382499: +32.0% average CAGR, $4.8B calculated opportunity.
- HS 330499: +29.9% average CAGR, $8.7B calculated opportunity.
- HS 300212: +17.9% average CAGR, $12.4B calculated opportunity.

## Diversification opportunities

- HS 300490: 31 buyer markets, $90.0B calculated opportunity.
- HS 300215: 14 buyer markets, $32.8B calculated opportunity.
- HS 300220: 12 buyer markets, $21.5B calculated opportunity.
- HS 382200: 9 buyer markets, $9.8B calculated opportunity.
- HS 330499: 8 buyer markets, $8.7B calculated opportunity.
- HS 300212: 7 buyer markets, $12.4B calculated opportunity.
- HS 300290: 6 buyer markets, $3.5B calculated opportunity.
- HS 330300: 5 buyer markets, $3.9B calculated opportunity.
- HS 330210: 4 buyer markets, $5.2B calculated opportunity.
- HS 382499: 4 buyer markets, $4.8B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.